Stock A115480 CU MEDICAL SYSTEMS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials CU Medical Systems, Inc.

Equities

A115480

KR7115480006

Medical Equipment, Supplies & Distribution

End-of-day quote Korea S.E.
Other stock markets
 23:00:00 30/05/2024 BST 		5-day change 1st Jan Change
750 KRW +1.49% Intraday chart for CU Medical Systems, Inc. -.--% -12.08%
05-16 CU Medical Systems, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
03-18 CU Medical Systems, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 35,372 50,749 66,577 51,576 59,540 41,050
Enterprise Value (EV) 1 73,087 101,625 90,205 54,640 72,256 54,878
P/E ratio 20 x -15.5 x -2.19 x -2.78 x 6.48 x -4.96 x
Yield - - - - - -
Capitalization / Revenue 0.46 x 0.62 x 2.35 x 1.46 x 1.27 x 0.98 x
EV / Revenue 0.96 x 1.24 x 3.19 x 1.54 x 1.54 x 1.31 x
EV / EBITDA 12.4 x 19.3 x -20.1 x 12.6 x 5.57 x 7.85 x
EV / FCF -1.99 x -11 x -20.3 x 79.6 x 6.04 x -11.1 x
FCF Yield -50.1% -9.13% -4.92% 1.26% 16.5% -9.01%
Price to Book 0.75 x 0.99 x 1.59 x 1.05 x 1.02 x 0.76 x
Nbr of stocks (in thousands) 15,791 18,255 26,263 45,045 45,624 48,125
Reference price 2 2,240 2,780 2,535 1,145 1,305 853.0
Announcement Date 07/03/19 16/03/20 02/04/21 18/03/22 17/03/23 18/03/24
1KRW in Million2KRW
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 76,304 81,794 28,319 35,402 46,957 41,803
EBITDA 1 5,893 5,260 -4,478 4,320 12,983 6,995
EBIT 1 3,604 2,437 -8,870 2,376 10,952 5,060
Operating Margin 4.72% 2.98% -31.32% 6.71% 23.32% 12.11%
Earnings before Tax (EBT) 1 2,951 -3,732 -18,290 -15,140 10,115 -7,443
Net income 1 1,750 -2,911 -25,740 -13,981 9,095 -8,204
Net margin 2.29% -3.56% -90.89% -39.49% 19.37% -19.62%
EPS 2 111.8 -179.4 -1,160 -412.1 201.5 -172.0
Free Cash Flow 1 -36,649 -9,278 -4,435 686.7 11,954 -4,944
FCF margin -48.03% -11.34% -15.66% 1.94% 25.46% -11.83%
FCF Conversion (EBITDA) - - - 15.9% 92.07% -
FCF Conversion (Net income) - - - - 131.43% -
Dividend per Share - - - - - -
Announcement Date 07/03/19 16/03/20 02/04/21 18/03/22 17/03/23 18/03/24
1KRW in Million2KRW
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 37,715 50,877 23,628 3,064 12,716 13,828
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) 6.4 x 9.673 x -5.276 x 0.7093 x 0.9794 x 1.977 x
Free Cash Flow 1 -36,649 -9,278 -4,435 687 11,954 -4,944
ROE (net income / shareholders' equity) 3.82% -5.66% -40.9% -29.8% 17% -14.3%
ROA (Net income/ Total Assets) 2.71% 1.3% -5.26% 1.92% 8.51% 3.63%
Assets 1 64,691 -223,755 489,701 -727,460 106,914 -225,753
Book Value Per Share 2 3,006 2,797 1,594 1,085 1,279 1,117
Cash Flow per Share 2 343.0 510.0 115.0 263.0 134.0 205.0
Capex 1 36,556 827 1,281 5,186 11,586 6,382
Capex / Sales 47.91% 1.01% 4.52% 14.65% 24.67% 15.27%
Announcement Date 07/03/19 16/03/20 02/04/21 18/03/22 17/03/23 18/03/24
1KRW in Million2KRW
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Medical Equipment, Supplies & Distribution

1st Jan change Capi.
CU MEDICAL SYSTEMS, INC. Stock CU Medical Systems, Inc.
-12.08% 26.1M
ABBOTT LABORATORIES Stock Abbott Laboratories
-7.16% 178B
MEDTRONIC PLC Stock Medtronic plc
-1.23% 107B
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-4.86% 67.04B
DEXCOM, INC. Stock DexCom, Inc.
-4.28% 47.23B
CENCORA, INC. Stock Cencora, Inc.
+10.32% 44.62B
HOYA CORPORATION Stock Hoya Corporation
+8.14% 42.5B
TERUMO CORPORATION Stock Terumo Corporation
+15.53% 25.22B
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
-5.88% 24.14B
ZIMMER BIOMET HOLDINGS, INC. Stock Zimmer Biomet Holdings, Inc.
-5.38% 23.69B
Other Medical Equipment, Supplies & Distribution
  1. Stock Market
  2. Equities
  3. A115480 Stock
  4. Financials CU Medical Systems, Inc.